BZAD-01
BZAD-01 is a potent, selective and orally active inhibitor of NMDA NR2B subunit, with a Ki of 72 nM. BZAD-01 can improve postural asymmetry as well as Apomorphine-induced rotation[1].
Product Specifications
CAS Number
[305339-41-7]
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bzad-01.html
Purity
99.81
Solubility
DMSO : 100 mg/mL (ultrasonic) |Methanol : 250 mg/mL (ultrasonic)
Smiles
N=C(NCC1=C(C(F)(F)F)C=CC=C1)C2=CC=C(C=C2)OC(F)(F)F
Molecular Formula
C16H12F6N2O
Molecular Weight
362.27
References & Citations
[1]Truong L, et, al. Behavioural effects of a selective NMDA NR1A/2B receptor antagonist in rats with unilateral 6-OHDA+parafascicular lesions. Brain Res Bull. 2009 Feb 16;78 (2-3) :91-6.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NMDA Receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6270410-01 0.2 mL
ABCC10, ID (ABCC10, MRP7, SIMRP7, Multidrug resistance-associated protein 7, ATP-binding cassette sub-family C member 10) (Biotin)
Ask
View Details MBS6270410-02 5x 0.2 mL
ABCC10, ID (ABCC10, MRP7, SIMRP7, Multidrug resistance-associated protein 7, ATP-binding cassette sub-family C member 10) (Biotin)
Ask
View Details 